Fernández-Rivera C, Torre-Cisneros J, Guirado-Perich L, Oyagüez I, Ruiz-Beato E
Cost-effectiveness modelto evaluate 200-day vs 100-day treatment with valganciclovir prophylaxis to reduce cytomegalovirus disease in high-risk (D+/R-) kidney transplant recipient in Spain
14th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Madrid, Spain 5-8 nov 2011
Collar JM
Different comparators for the same new drug?
13th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Prague, Czech Republic. 6-9 nov 2010
Collar JM
The Joint Committee for New Drugs Evaluation in Spain: six years of experience
13th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Prague, Czech Republic. 6-9 nov 2010
Román A, Barberá JA, Escribano P, Sala ML, Febrer L, Casado MA
Economic evaluation of iloprost, epoprostenol and treprostinil for the treatment of pulmonary arterial hypertensione
13th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Prague, Czech Republic. 6-9 nov 2010
Martinez-Moragon E, Palop M, de Diego A, Serra J, Caloto T, Nocea G, Sabater E
Factors affecting quality of life (QOL) of asthmatic patients in Spain
13th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Prague, Czech Republic. 6-9 nov 2010
Picazo J, Mendez C, Oyagüez I, Casado MA, Guijarro PA
Cost-utility analysis of new pneumococcal conjugate vaccines in the regional immunization program of the Autonomous Region of Madrid – Impact on invasive pneumococcal disease
13th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Prague, Czech Republic. 6-9 nov 2010
Marinello J, March JR, Blanes JI, Martínez-Aguilar E, Escudero JR, Masegosa A, Lizano C, Massó JM, Yébenes M, Casado MA
Cost of an episode of diabetic foot ulcer in Spain
12th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Paris, France. 24-27 oct 2009
Cortés J, Seguí MA, Frias C, Betegón L, Oyagüez I, Casado MA
Cost-effectiveness analyses of docetaxel versus paclitaxel once weekly in patients with metastatic breast cancer progressed after anthracycline chemotherapy in Spain
12th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Paris, France. 24-27 oct 2009
Sanchez-Carazo JL, Dauden E, Vanaclocha F, Toribio J, Pujol R Puig Ll, Yébenes M, Sabater FJ